You can buy or sell NGM and other stocks, options, ETFs, and crypto commission-free!
NGM Biopharmaceuticals, Inc. Common Stock, also called NGM Biopharmaceuticals, is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for cardio-metabolic, liver, oncologic, and ophthalmic diseases. Read More Its portfolio include aldafermin (NGM282), NGM313, NGM120, NGM217, NGM621, and NGM395. The company was founded by Jin-Long Chen in 2008 and is headquartered in South San Francisco, CA.
South San Francisco, California
52 Week High
52 Week Low
— per share
Expected May 14, After Hours